Projects per year
Personal profile
Personal profile
Dr. Ganguly is a board-certified hematologist specializing in the clinical care and research of hematological malignancies, cellular therapeutics, and bone marrow transplantation. Dr. Ganguly was a A. Drue Jennings endowed professor of medical oncology at the University of Kansas Cancer Center in Westwood, Kansas where he was also the Deputy Director of the Division of Hematological Malignancies and Cellular Therapeutics, the Associate Director of Blood and Marrow Transplantation Program, and the Director of Lymphoma and Myeloma Program.
Dr. Ganguly received his undergraduate degree from Calcutta Medical College and his medical degree from the Department of Internal Medicine, Post Graduate, Institute of Medical Education and Research in India. Additionally, he completed his residency in internal medicine and fellowship in hematology at Baylor College of Medicine and concluded another fellowship in bone marrow transplantation at Baylor College of Medicine, Center for Cell and Gene Therapy.
External positions
Professor of Clinical Medicine, Weill Cornell Medical College
May 1 2022 → …
Research Area Keywords
- Cancer
Fingerprint
Dive into the research topics where Siddhartha Ganguly is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
8/23/21 → …
Project: Clinical Trial
-
Phase 3_NavitoclaxRuxolitinib_Myelofibrosis_Abbvie M20-178 Transform-2
Shah, S., Ganguly, S., Pingali, S. R. & Rice, L.
6/7/21 → …
Project: Clinical Trial
-
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial
-
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission
Shadman, M., Pasquini, M., Ahn, K. W., Chen, Y., Turtle, C. J., Hematti, P., Cohen, J. B., Khimani, F., Ganguly, S., Merryman, R. W., Yared, J. A., Locke, F. L., Ahmed, N., Munshi, P. N., Beitinjaneh, A., Reagan, P. M., Herrera, A. F., Sauter, C. S., Kharfan-Dabaja, M. A. & Hamadani, M., Mar 3 2022, In: Blood. 139, 9, p. 1330-1339 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
Bhatt, V. R., Wang, T., Chen, K., Kitko, C. L., MacMillan, M. L., Pidala, J. A., Al Malki, M. M., Badawy, S. M., Beitinjaneh, A., Ganguly, S., Hamilton, B., Hildebrandt, G. C., Lekakis, L. J., Liu, H., Maziarz, R. T., Modi, D., Murthy, H. S., Preussler, J. M., Sharma, A., Spellman, S. R. & 2 others, , Jan 2022, In: Transplantation and Cellular Therapy. 28, 1, p. 34-42 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Functional characterization of NPM1–TYK2 fusion oncogene
Kuravi, S., Baker, R. W., Mushtaq, M. U., Saadi, I., Lin, T. L., Vivian, C. J., Valluripalli, A., Abhyankar, S., Ganguly, S., Cui, W., Elenitoba-Johnson, K. S. J., Welch, D. R., Jensen, R. A., Saunthararajah, Y., McGuirk, J. P. & Balusu, R., Dec 2022, In: npj Precision Oncology. 6, 1, 3.Research output: Contribution to journal › Article › peer-review
Open Access -
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
Wieduwilt, M. J., Metheny, L., Zhang, M. J., Wang, H. L., Estrada-Merly, N., Marks, D. I., Samer Al-Homsi, A., Muffly, L., Chao, N., Rizzieri, D., Gale, R. P., Gadalla, S. M., Cairo, M., Mussetti, A., Gore, S., Bhatt, V. R., Patel, S. S., Michelis, F. V., Inamoto, Y., Badawy, S. M. & 57 others, , Jan 11 2022, In: Blood Advances. 6, 1, p. 339-357 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
Murthy, H. S., Ahn, K. W., Estrada-Merly, N., Alkhateeb, H. B., Bal, S., Kharfan-Dabaja, M. A., Dholaria, B., Foss, F., Gowda, L., Jagadeesh, D., Sauter, C., Abid, M. B., Aljurf, M., Awan, F. T., Bacher, U., Badawy, S. M., Battiwalla, M., Bredeson, C., Cerny, J., Chhabra, S. & 41 others, , Apr 2022, In: Transplantation and Cellular Therapy. 28, 4, p. 187.e1-187.e10Research output: Contribution to journal › Article › peer-review
Open Access